Neoadjuvant Therapy: Where are we in 2016?

Neoadjuvant Therapy: Where are we in 2016?

kidneycancer

3 years
723 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Ithaar H. Derweesh, M.D., University of California, San Diego asks the question "Neoadjuvant Therapy: Where are we in 2016?" at the 2016 annual International Kidney Cancer Symposium.
Up Next Autoplay
Role of Radiation in Kidney Cancer
Role of Radiation in Kidney Cancer
Category: Kidney Cancer
35 Views
kidneycancer 1 week
Treatment-Free Survival, With and Without Toxicity
Treatment-Free Survival, With and Without Toxicity
Category: Kidney Cancer
43 Views
kidneycancer 1 month
Phase 2 Study of Lenvatinib Plus Pembrolizumab for Disease Progression After PD-1/PD-L1
Phase 2 Study of Lenvatinib Plus Pembrolizumab for Disease Progression After PD-1/PD-L1
Category: Kidney Cancer
22 Views
kidneycancer 1 month
What's To Come in Modern Imaging Technology
What's To Come in Modern Imaging Technology
Category: Kidney Cancer
6 Views
kidneycancer 1 month
Modern Imaging Technology
Modern Imaging Technology
Category: Kidney Cancer
14 Views
kidneycancer 1 month
Management of Clinical Cases in Kidney Cancer
Management of Clinical Cases in Kidney Cancer
Category: Kidney Cancer
49 Views
kidneycancer 1 month
Kidney Cancer Program & SPORE
Kidney Cancer Program & SPORE
Category: Kidney Cancer
18 Views
kidneycancer 1 month
Front Line TKI Based Treatment For Non-Clear Cell RCC
Front Line TKI Based Treatment For Non-Clear Cell RCC
Category: Kidney Cancer
41 Views
kidneycancer 1 month
Consolidative Surgery in the IO Era @WinshipAtEmory
Consolidative Surgery in the IO Era @WinshipAtEmory
Category: Kidney Cancer
20 Views
kidneycancer 1 month
Management of Small Renal Masses @RutgersCancer @eric_facs
Management of Small Renal Masses @RutgersCancer @eric_facs
Category: Kidney Cancer
26 Views
kidneycancer 1 month